STOCK TITAN

MGRM options grant: 5,000 at $2.50; exercisable 01/08/2032

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Monogram Technologies (MGRM) reported an insider equity award. A director filed a Form 4 for a grant (Code A) of stock options on 01/08/2025 covering 5,000 underlying shares at an exercise price of $2.50 per share. The options are listed as exercisable on 01/08/2032 and expiring on 01/08/2035. Following the reported transaction, the filer shows 8,000 derivative securities beneficially owned, held directly. The company notes it uses the Black‑Scholes‑Merton model to determine the fair value of stock awards.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Gray Colleen

(Last) (First) (Middle)
3913 TODD LANE

(Street)
AUSTIN TX 78744

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Monogram Technologies Inc. [ MGRM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $2.5 01/08/2025 A 5,000 01/08/2032 01/08/2035 Common Stock 5,000 (1) 8,000 D
Explanation of Responses:
1. The Company uses the Black-Scholes-Merton ("Black-Scholes") option-pricing model to determine the fair value of stock awards. The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions, including the estimated fair value and price volatility of the Company's common stock and the expected term of the option.
/s/ Colleen Gray 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MGRM disclose in this Form 4?

A director reported a grant (Code A) of stock options for 5,000 shares at an exercise price of $2.50 on 01/08/2025.

How many options and at what price were granted to the MGRM director?

The filing shows 5,000 stock options with an exercise price of $2.50 per share.

When are the MGRM options exercisable and when do they expire?

They are listed as exercisable on 01/08/2032 and expiring on 01/08/2035.

What is the total derivative securities owned after the transaction?

The Form 4 shows 8,000 derivative securities beneficially owned following the transaction.

What role does the reporting person hold at MGRM?

The reporting person is a Director.

How does MGRM value its stock awards?

MGRM uses the Black‑Scholes‑Merton option‑pricing model to determine fair value.

Is the ownership direct or indirect?

The filing lists the ownership form as Direct.
Monogram Orthopaedics Inc

NASDAQ:MGRM

MGRM Rankings

MGRM Latest News

MGRM Latest SEC Filings

MGRM Stock Data

243.79M
18.47M
54.55%
4.97%
0.38%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
AUSTIN